Real-time enrollment status for this relapsed and/or refractory b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:40 AM UTC
| NCT Number | NCT04989803 |
| Recruiting Status | Recruiting |
| Condition | Relapsed and/or Refractory B-cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 247 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Kite, A Gilead Company |
| Last Updated on CT.gov | June 29, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT04989803 is currently recruiting participants. This clinical trial study for relapsed and/or refractory b-cell lymphoma is actively seeking new participants at 17 locations across the United States. The study is sponsored by Kite, A Gilead Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04989803 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04989803 was last updated 2 weeks ago (June 29, 2026). HelloStudys verifies this status automatically.